Drug Candidate to Treat CKD-Related Anemia Performs Well in Early Clinical Study, Company Reports
News
Akebia Therapeutics, Inc., has released positive results from a drug-drug interaction study evaluating vadadustat, an oral medicine to treat anemia related to chronic kidney disease (CKD). The results indicate that vadadustat may be ... Read more